Department of Occupational Medicine, University of Rome Tor Vergata, Viale Oxford 81, 00188 Roma, Italy.
Department of Occupational Diseases, Toulouse University Hospital, Bâtiment Turiaf, Place du Dr Baylac, 31059, Toulouse Cedex 9, France.
Int J Environ Res Public Health. 2019 Apr 29;16(9):1515. doi: 10.3390/ijerph16091515.
Immunization of healthcare workers (HCWs) and medical students for the hepatitis B virus (HBV) is a crucial part of the hospital infection control programs. The aim of our study was to evaluate the persistence of anti-HBV specific antibodies in HCWs vaccinated during infancy or adolescence. Medical records of 734 consecutive subjects born after 1980 (481 females, 65.5% and 253 males, 34.5%) who underwent serological testing for anti-hepatitis B surface antibodies (anti-HBs) were evaluated. A non-protective titer (<10 mUI) was found in 88/734 (12.0%) subjects; 84 (47.8%) of them received a booster dose of anti-hepatitis B vaccine and the anti-HBs titer of 58 subjects was measured 1 month after administration. A protective titer (anti-HBs >10 mIU/mL) was observed in almost 90% of subjects receiving the booster dose. A substantial percentage of HCWs had a non-protective anti-HBs titer at the time of the first employment, especially those vaccinated at birth age. However, the response to the booster dose showed that in these subjects, an anti-HBs titer <10 mIU/mL was due to the physiological decline of antibodies over the years. Therefore, primary immunization in childhood is highly effective and provides lasting immunity against HBV infection.
为乙型肝炎病毒 (HBV) 而对医护人员 (HCWs) 和医学生进行免疫接种是医院感染控制计划的重要组成部分。我们的研究目的是评估在婴儿期或青春期接种乙型肝炎疫苗的 HCWs 体内乙型肝炎表面抗体 (抗-HBs) 特异性抗体的持久性。对 734 名连续出生于 1980 年后的受试者(女性 481 名,占 65.5%;男性 253 名,占 34.5%)的血清学检测抗乙型肝炎表面抗体 (抗-HBs) 的医学记录进行了评估。在 734 名受试者中,有 88 名(12.0%)的抗-HBs 滴度较低(<10 mIU);其中 84 名(47.8%)接受了乙型肝炎疫苗加强剂注射,58 名受试者在注射后 1 个月测量了抗-HBs 滴度。接受加强剂注射的受试者中,几乎 90%的受试者的抗-HBs 滴度达到保护水平(抗-HBs >10 mIU/mL)。在首次就业时,相当一部分 HCWs 的抗-HBs 滴度较低,特别是那些在出生时接种疫苗的 HCWs。然而,加强剂注射的反应表明,在这些受试者中,抗-HBs 滴度<10 mIU/mL 是由于多年来抗体的生理性下降。因此,儿童时期的基础免疫非常有效,可提供针对 HBV 感染的持久免疫力。